Coenzyme Q<sub>0</sub> Inhibits NLRP3 Inflammasome Activation through Mitophagy Induction in LPS/ATP‐Stimulated Macrophages
You‐Cheng Hseu, Yu‐Fang Tseng, Sudhir Pandey, Sirjana Shrestha, Kai‐Yuan Lin, Cheng‐Wen Lin, Chuan-Chen Lee, Sheng‐Teng Huang, Hsin‐Ling Yang
Abstract
Coenzyme Q (CoQ) analogs with a variable number of isoprenoid units have exhibited as anti‐inflammatory as well as antioxidant molecules. Using novel quinone derivative CoQ 0 (2,3‐dimethoxy‐5‐methyl‐1,4‐benzoquinone, zero side chain isoprenoid), we studied its molecular activities against LPS/ATP‐induced inflammation and redox imbalance in murine RAW264.7 macrophages. CoQ 0 ’s non‐ or subcytotoxic concentration suppressed the NLRP3 inflammasome and procaspase‐1 activation, followed by downregulation of IL1 β expression in LPS/ATP‐stimulated RAW264.7 macrophages. Similarly, treatment of CoQ 0 led to LC3‐I/II accumulation and p62/SQSTM1 activation. An increase in the Beclin‐1/Bcl‐2 ratio and a decrease in the expression of phosphorylated PI3K/AKT, p70 S6 kinase, and mTOR showed that autophagy was activated. Besides, CoQ 0 increased Parkin protein to recruit damaged mitochondria and induced mitophagy in LPS/ATP‐stimulated RAW264.7 macrophages. CoQ 0 inhibited LPS/ATP‐stimulated ROS generation in RAW264.7 macrophages. Notably, when LPS/ATP‐stimulated RAW264.7 macrophages were treated with CoQ 0 , Mito‐TEMPO (a mitochondrial ROS inhibitor), or N ‐acetylcysteine (NAC, a ROS inhibitor), there was a significant reduction of LPS/ATP‐stimulated NLRP3 inflammasome activation and IL1 β expression. Interestingly, treatment with CoQ 0 or Mito‐TEMPO, but not NAC, significantly increased LPS/ATP‐induced LC3‐II accumulation indicating that mitophagy plays a key role in the regulation of CoQ 0 ‐inhibited NLRP3 inflammasome activation. Nrf2 knockdown significantly decreased IL1 β expression in LPS/ATP‐stimulated RAW264.7 macrophages suggesting that CoQ 0 inhibited ROS‐mediated NLRP3 inflammasome activation and IL1 β expression was suppressed due to the Nrf2 activation. Hence, this study showed that CoQ 0 might be a promising candidate for the therapeutics of inflammatory disorders due to its effective anti‐inflammatory as well as antioxidant properties.